Kasper Bruun Kristensen
Overview
Explore the profile of Kasper Bruun Kristensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahbek M, Just S, Kristensen K, Sheta H, Hallas J, Pottegard A, et al.
J Intern Med
. 2024 Oct;
296(6):527-530.
PMID: 39440625
No abstract available.
2.
Hicks B, Kaye J, Azoulay L, Kristensen K, Habel L, Pottegard A
Ann Epidemiol
. 2023 May;
84:25-32.
PMID: 37169040
Purpose: With the increasing utilization of medications worldwide, coupled with the increasing availability of long-term data, there is a growing opportunity and need for robust studies evaluating drug-cancer associations. One...
3.
Bonnelykke-Behrndtz M, Kristensen K, Holmich L, Pottegard A
Cancer Epidemiol
. 2023 Mar;
84:102356.
PMID: 36996688
Background: Repurposing already approved drugs in a cancer setting has gained increasing interest in recent years. Tranexamic acid is an anti-fibrinolytic drug that has recently been suggested as an anti-cancer...
4.
Kristensen K, Friis S, Lund L, Hallas J, Cardwell C, Andreassen B, et al.
Cancer Res Commun
. 2023 Mar;
2(6):552-560.
PMID: 36923552
Significance: This study provides a screening tool for drug carcinogenicity aimed at hypothesis generation and explorative purposes. As such, the study may help to identify drugs with unknown carcinogenic effects...
5.
Reyes C, Leon-Munoz L, Pistillo A, Schmidt S, Kristensen K, Puente D, et al.
Front Pharmacol
. 2023 Jan;
13:1002451.
PMID: 36618916
A previous study in Denmark suggested an increased melanoma risk associated with the use of flecainide. To study the association between flecainide use and the risk of melanoma and non-melanoma...
6.
Kristensen K, Lund L, Jensen P, Broe A, Rotbain E, Damkier P, et al.
Clin Epidemiol
. 2022 May;
14:567-579.
PMID: 35509520
Purpose: To develop the Nordic Multimorbidity Index (NMI), a multimorbidity measure specifically suited to the Nordic health and administrative registry data based on current diagnosis, treatment, and coding practices. Methods:...
7.
Lund L, Hojlund M, Henriksen D, Hallas J, Kristensen K
Pharmacoepidemiol Drug Saf
. 2021 Nov;
31(1):114-115.
PMID: 34729863
No abstract available.
8.
Cortes-Figueiredo F, Nielsen N, Stenager E, Paul F, Hallas J, Kristensen K
Eur J Neurol
. 2021 Sep;
29(1):247-256.
PMID: 34536255
Background And Purpose: Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system with an undetermined etiology. Retinoids may have immunomodulatory effects that favorably influence MS progression....
9.
Lund L, Hojlund M, Henriksen D, Hallas J, Kristensen K
Pharmacoepidemiol Drug Saf
. 2021 Apr;
30(10):1391-1395.
PMID: 33881179
Purpose: Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) are frequently used in type 2 diabetes and have recently been associated with lower rates of gout compared to glucagon-like peptide-1 receptor agonists (GLP1-RA). Our...
10.
Kristensen K, Hicks B, Azoulay L, Pottegard A
Circ Cardiovasc Qual Outcomes
. 2021 Jan;
14(1):e006687.
PMID: 33435729
Background: Use of angiotensin-converting enzyme inhibitors (ACEIs)was associated with increased risk of lung cancer in a cohort study from the United Kingdom. We aimed to replicate these findings in a...